Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypomethylating Agent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05285813
What this trial is testing

A Phase II Study of Vibecotamab (XmAb14045) for MRD- Positive AML and MDS After Hypomethylating Agent Failure

Who this might be right for
AMLMDS
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT07148947
What this trial is testing

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

Who this might be right for
Accelerated Phase Myeloproliferative NeoplasmBlast Phase Myeloproliferative Neoplasm
University of Washington 27
Testing effectiveness (Phase 2)Ended earlyNCT03146871
What this trial is testing

Recombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic Syndrome+2 more
University of Southern California 7
Testing effectiveness (Phase 2)Study completedNCT03264404
What this trial is testing

Azacitidine and Pembrolizumab in Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Susan E. Bates 36
Testing effectiveness (Phase 2)Study completedNCT02019069
What this trial is testing

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Adult Acute Erythroid Leukemia (M6)Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+13 more
Rondeep Brar 11
Early research (Phase 1)Study completedNCT00349596
What this trial is testing

Low-Dose Decitabine in Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)

Who this might be right for
Acute Lymphocytic Leukemia
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03957876
What this trial is testing

CPX-351 Therapy for MDS After Hypomethylating Agent Failure

Who this might be right for
Myelodysplastic Syndrome (MDS)
Case Comprehensive Cancer Center 4
Not applicableStudy completedNCT01400633
What this trial is testing

An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Janssen Korea, Ltd., Korea 156
Early research (Phase 1)Study completedNCT05564650
What this trial is testing

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeRecurrent Myelodysplastic SyndromeRefractory Myelodysplastic Syndrome
Thomas Jefferson University 6
Testing effectiveness (Phase 2)Looking for participantsNCT07238686
What this trial is testing

Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS

Who this might be right for
Myelodysplastic Syndromes
Beijing 302 Hospital 40
Testing effectiveness (Phase 2)Study completedNCT03140280
What this trial is testing

Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)

Who this might be right for
Myelodysplastic Syndromes
Ehab L Atallah 23
Early research (Phase 1)Study completedNCT00671697
What this trial is testing

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Who this might be right for
Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
Washington University School of Medicine 13
Testing effectiveness (Phase 2)Study completedNCT01261312
What this trial is testing

SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Who this might be right for
MDSCMMLAML
Astex Pharmaceuticals, Inc. 414
Testing effectiveness (Phase 2)Study completedNCT02159872
What this trial is testing

Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 48
Early research (Phase 1)Not Yet RecruitingNCT07814339
What this trial is testing

Hydrochloroquinine & Decitabine With Venetoclax in AML

Who this might be right for
Acute Myeloid Leukemia
Rutgers, The State University of New Jersey 18